Treace Medical Concepts, Inc. (TMCI) stock
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3016% below fair value
$5.27−0.07 (-1.31%)
Close on Nov 13, 2026Market cap $342.73MP/E –Yield –
Treace Medical Concepts EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Treace Medical Concepts's EV/EBITDA was 680.3× on Jul 30, 2021.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Jul 30, 2021 | 680.3× | – |
See a number that looks wrong?